|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02727725 |
|
Date of registration:
|
24/02/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images
|
|
Scientific title:
|
Establishing the Clinical Usefulness Of Dark Blood Late Gadolinium Enhancement Images For The Detection Of Small Subendocardial Left Ventricular Infarcts - An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images |
|
Date of first enrolment:
|
January 15, 2016 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02727725 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Nayla Chaptini |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Advocate Lutheran General Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Adults =18 years of age referred for a cardiac MRI with Gadolinium enhancement only at
Advocate Lutheran General Hospital
Exclusion Criteria:
- <18 years old,
- Adults unable to consent
- Adults for whom the MRI has not been previously scheduled
- Adults with an order for any MRI other than cardiac MRI with Gadolinium enhancement
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiovascular Disease
|
|
Myocardial Fibrosis
|
|
Intervention(s)
|
|
Other: Traminer MRI Sequence
|
|
Primary Outcome(s)
|
|
Sensitivity of the TRAMINER sequence in detecting myocardial fibrosis or acute infarction compared to the gold standard sequence will be measured.
[Time Frame: 6-12 months]
|
|
Secondary Outcome(s)
|
|
Reduction in clinical Magnetic Resonance (MRI) procedure time.
[Time Frame: 6-12 months]
|
|
Secondary ID(s)
|
|
AHC IRB 5886
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|